Figure 2.

Therapeutic results of radioimmunotherapy (RIT) with ²¹¹At‐OTSA101 and ⁹⁰Y‐OTSA101 in the synovial sarcoma (SS) subcutaneous xenograft mouse model. Changes in tumor volumes in the model mice after RIT with ²¹¹At‐OTSA101 (A) and ⁹⁰Y‐OTSA101 (B) are shown. Plots were interrupted if the animal reached the defined endpoint. Kaplan‐Meier survival curves of mice after RIT with ²¹¹At‐OTSA101 (C) and ⁹⁰Y‐OTSA101 (D). Five mice were enrolled in each of the treatment groups, except for the intact IgG control (4 mice). *P < .05, **P < .01, vs intact IgG control